antivenom serum

Antivenom serum produced by Jiangxi Serum Pharma (also known as Jiangxi Biological Products Co., Ltd.) is a passive immunotherapeutic agent used for the treatment of snake envenomation and venom poisoning. These products are equine-derived antisera containing purified polyclonal antibodies, typically in the F(ab')2 fragment form, obtained from the plasma of horses immunized with specific snake venoms. The mechanism of action involves the antibodies binding to and neutralizing circulating venom toxins (such as neurotoxins, hemotoxins, and cytotoxins), thereby preventing them from interacting with their physiological targets and mitigating systemic toxicity. Jiangxi Serum Pharma is a primary manufacturer in China, offering specific antivenoms for various indigenous species, including the many-banded krait (*Bungarus multicinctus*), Chinese cobra (*Naja atra*), and several viper species like *Agkistrodon halys* and *Deinagkistrodon acutus*. The company's pipeline includes ongoing R&D projects to develop new varieties of antiserum products and improve manufacturing processes to fill domestic gaps in China.

Other names

antiserumantiveninsnake antivenomsnake venom antiserum